Bardin Hill Management Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-206,867
Closed -$4.77M 109
2020
Q4
$4.77M Buy
+206,867
New +$4.77M 1% 27